Document is current
Any future updates will be listed below
-
Authors
von Seidlein, Lorenz https://orcid.org/0000-0002-0282-6469
Peerawaranun, Pimnara
Mukaka, Mavuto
Nosten, Francois H.
Nguyen, Thuy-Nhien
Hien, Tran Tinh
Tripura, Rupam
Peto, Thomas J.
Pongvongsa, Tiengkham
Phommasone, Koukeo
Mayxay, Mayfong
Imwong, Mallika
Watson, James
Pukrittayakamee, Sasithon
Day, Nicholas P. J.
Dondorp, Arjen M.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01872702 at ClinicalTrials.govnct02802813 at ClinicalTrials.govDocuments that mention this clinical trial
Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials
https://doi.org/10.1186/s12936-019-3062-x
Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia
https://doi.org/10.1186/s12936-018-2390-6
Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia
https://doi.org/10.1186/s12936-017-1703-5
The dynamic of asymptomatic Plasmodium falciparum infections following mass drug administrations with dihydroarteminisin–piperaquine plus a single low dose of primaquine in Savannakhet Province, Laos
https://doi.org/10.1186/s12936-018-2541-9
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
https://doi.org/10.1186/s12936-019-3087-1
Documents that mention this clinical trial
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
https://doi.org/10.1186/s12936-019-3091-5
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
https://doi.org/10.1186/s12936-019-3087-1
-
Funding
Funding for this research was provided by:
Wellcome Trust (101148/Z/13/Z)
Bill and Melinda Gates Foundation (OPP10811420)
- License Information
-
More Information
Article History
Received: 25 November 2019
Accepted: 21 December 2019
First Online: 30 December 2019
Ethics approval and consent to participate
: The studies were approved by the Cambodian National Ethics Committee for Health Research (0029 NECHR, dated 04 Mar 2013) the Institute of Malariology, Parasitology and Entomology in Ho Chi Minh City (185/HDDD dated 15 May 2013), the Institute of Malariology, Parasitology and Entomology in Qui Nhon (dated 14 Oct 2013), the Lao National Ethics Committee for Health Research (Ref No 013-2015/NECHR), Government of the Lao PDR and the Oxford Tropical Research Ethics Committee (1015-13, dated 29 Apr 2013). Each participant or parent/guardian in the case on minors provided Individual, signed, informed consent or a fingerprint for illiterate participants countersigned by a literate witness. (ClinicalTrials.gov Identifier: NCT01872702).
: Not applicable as no personal data are included.
: The authors declare that they have no competing interests.
